{"id":215660,"date":"2024-06-27T10:57:07","date_gmt":"2024-06-27T14:57:07","guid":{"rendered":"https:\/\/www.breakthrought1d.org\/explora-investigacion\/curando-dt1\/terapias-modificadoras-de-la-enfermedad\/"},"modified":"2025-07-16T13:50:51","modified_gmt":"2025-07-16T17:50:51","slug":"terapias-modificadoras-de-la-enfermedad","status":"publish","type":"page","link":"https:\/\/www.breakthrought1d.org\/es\/explora-investigacion\/cura-dt1\/terapias-modificadoras-de-la-enfermedad\/","title":{"rendered":"Terapias modificadoras de la enfermedad"},"content":{"rendered":"\n<div class=\"page-header alignfull wp-block-jdfr-page-header\">\n\t<div class=\"page-header__inner-container\">\n\t\t\n<nav id=\"breadcrumbs\" class=\"site-breadcrumbs alignfull\" aria-label=\"Breadcrumbs\">\n\t<ul class=\"site-breadcrumbs__inner\"><li class=\"breadcrumb-item\"><a href=\"https:\/\/www.breakthrought1d.org\/es\/pagina-de-actualizacion-de-test\/\">Inicio<\/a><\/li><li class=\"site-breadcrumbs__separator\"><?xml version=\"1.0\"?>\n<svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"9.143\" height=\"16\" fill=\"currentColor\" viewBox=\"0 0 9.143 16\" aria-hidden=\"true\"><path d=\"M1.143 16a1.143 1.143 0 0 1-.808-1.951L6.384 8 .335 1.951A1.143 1.143 0 0 1 1.951.335l6.857 6.857a1.143 1.143 0 0 1 0 1.616l-6.857 6.857a1.14 1.14 0 0 1-.808.335\"\/><\/svg>\n<\/li><li class=\"breadcrumb-item\" aria-current=\"page\" tabindex=\"0\" role=\"text\" aria-label=\"P\u00e1gina actual: \"><\/li><\/ul><\/nav>\n\n\t\t<div class=\"page-header__content\">\n\t\t\t<h1 class=\"page-header__title\">Terapias modificadoras de la condici\u00f3n <a href=\"http:\/\/mms.tveyes.com\/PlaybackPortal.aspx?SavedEditID=5f773782-ec50-4c4d-807d-f3b04cc9e86f\u00a0\n\nThis link is for internal\nreporting purposes.\">Disease-modifying therapies<\/a><\/h1><div class=\"page-header__description\"><p>C\u00f3mo podemos disminuir la velocidad, parar y revertir la diabetes tipo 1<\/p>\n<\/div>\n\t\t\t\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-group alignfull has-gradient is-layout-constrained wp-block-group-is-layout-constrained\">\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-e50f5278 wp-block-columns-is-layout-flex has-2-columns\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<h2 class=\"wp-block-heading\" id=\"content-block-b-body-copy-image-video\">Nuestro enfoque<\/h2>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<p class=\"wp-block-paragraph\">La diabetes tipo 1 (DT1) es una condici\u00f3n autoinmune en la que el sistema inmunol\u00f3gico del organismo destruye las c\u00e9lulas beta del p\u00e1ncreas, haci\u00e9ndolas dependientes de por vida de la administraci\u00f3n externa de insulina. Breakthrough T1D se centra en desarrollar f\u00e1rmacos, o terapias modificadoras de la condici\u00f3n, que cambien el curso de la DT1 de todos los afectados por ella -y de los que a\u00fan no lo est\u00e1n-. Eso significa ralentizar o detener la progresi\u00f3n de la condici\u00f3n, evitar que llegue a producirse y revertirla por completo<em>.<\/em><\/p>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-bee6419c wp-block-columns-is-layout-flex has-2-columns\" style=\"margin-top:var(--wp--preset--spacing--40)\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"876\" height=\"876\" src=\"https:\/\/www.breakthrought1d.org\/wp-content\/uploads\/2024\/06\/BreakthroughT1D-Icon_Blues_RGB__Immunce-activation.png\" alt=\"Terapias inmunol\u00f3gicas que impiden que el aistema inmunol\u00f3gico ataque las c\u00e9lulas beta saludables\" class=\"wp-image-213320\" style=\"object-fit:cover;width:150px;height:150px\" srcset=\"https:\/\/www.breakthrought1d.org\/wp-content\/uploads\/2024\/06\/BreakthroughT1D-Icon_Blues_RGB__Immunce-activation.png 876w, https:\/\/www.breakthrought1d.org\/wp-content\/uploads\/2024\/06\/BreakthroughT1D-Icon_Blues_RGB__Immunce-activation-300x300.png 300w, https:\/\/www.breakthrought1d.org\/wp-content\/uploads\/2024\/06\/BreakthroughT1D-Icon_Blues_RGB__Immunce-activation-150x150.png 150w, https:\/\/www.breakthrought1d.org\/wp-content\/uploads\/2024\/06\/BreakthroughT1D-Icon_Blues_RGB__Immunce-activation-768x768.png 768w, https:\/\/www.breakthrought1d.org\/wp-content\/uploads\/2024\/06\/BreakthroughT1D-Icon_Blues_RGB__Immunce-activation-250x250.png 250w, https:\/\/www.breakthrought1d.org\/wp-content\/uploads\/2024\/06\/BreakthroughT1D-Icon_Blues_RGB__Immunce-activation-800x800.png 800w\" sizes=\"auto, (max-width: 876px) 100vw, 876px\" \/><\/figure>\n\n\n\n<h3 class=\"wp-block-heading has-h-5-font-size\" id=\"immune-therapies-stop-the-immune-system-from-attacking-healthy-beta-cells\">Las terapias inmunol\u00f3gicas impiden que el sistema inmunol\u00f3gico ataque a las c\u00e9lulas beta sanas.<\/h3>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"876\" height=\"876\" src=\"https:\/\/www.breakthrought1d.org\/wp-content\/uploads\/2024\/06\/BreakthroughT1D-Icon_Blues_RGB__Petri-Dish.png\" alt=\"Terapias con c\u00e9lulas beta que conservan o restauran la capacidad de las c\u00e9lulas beta para producir insulina\" class=\"wp-image-213324\" style=\"object-fit:cover;width:150px;height:150px\" srcset=\"https:\/\/www.breakthrought1d.org\/wp-content\/uploads\/2024\/06\/BreakthroughT1D-Icon_Blues_RGB__Petri-Dish.png 876w, https:\/\/www.breakthrought1d.org\/wp-content\/uploads\/2024\/06\/BreakthroughT1D-Icon_Blues_RGB__Petri-Dish-300x300.png 300w, https:\/\/www.breakthrought1d.org\/wp-content\/uploads\/2024\/06\/BreakthroughT1D-Icon_Blues_RGB__Petri-Dish-150x150.png 150w, https:\/\/www.breakthrought1d.org\/wp-content\/uploads\/2024\/06\/BreakthroughT1D-Icon_Blues_RGB__Petri-Dish-768x768.png 768w, https:\/\/www.breakthrought1d.org\/wp-content\/uploads\/2024\/06\/BreakthroughT1D-Icon_Blues_RGB__Petri-Dish-250x250.png 250w, https:\/\/www.breakthrought1d.org\/wp-content\/uploads\/2024\/06\/BreakthroughT1D-Icon_Blues_RGB__Petri-Dish-800x800.png 800w\" sizes=\"auto, (max-width: 876px) 100vw, 876px\" \/><\/figure>\n\n\n\n<h3 class=\"wp-block-heading has-h-5-font-size\" id=\"beta-cell-therapies-that-preserve-or-restore-beta-cells-ability-to-produce-insulin\">Terapias de c\u00e9lulas beta que preservan o restauran la capacidad de las c\u00e9lulas beta para producir insulina.<\/h3>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n<section class=\"wp-block-jdrf-timeline\">\n\t\t\t<h2 class=\"wp-block-jdrf-timeline__title\">Avances de la investigaci\u00f3n en terapias modificadoras de la condici\u00f3n<\/h2>\n\t\n\t\n\t<div class=\"wp-block-jdrf-timeline__entries\">\n\t\t\n<div class=\"wp-block-jdrf-timeline-year\">\n\t\t\t<h3 class=\"wp-block-jdrf-timeline-year__year\">2023<\/h3>\n\t\n\t<div class=\"wp-block-jdrf-timeline-year__list\">\n\t\t\n<div data-motion-direction=right class=\"motion wp-block-jdrf-timeline-event\">\n\t\n\t<div class=\"wp-block-jdrf-timeline-event__content\">\n\t\t\t\t\t<span class=\"wp-block-jdrf-timeline-event__byline\">Diciembre de 2023<\/span>\n\t\t\n\t\t\t\t\t\t\t\t\t<h4 class=\"wp-block-jdrf-timeline-event__title\">La inmunoterapia aprobada por la FDA muestra beneficios en reci\u00e9n diagnosticados<\/h4>\n\t\t\t\t\t\n\t\t\t\t\t<p class=\"wp-block-jdrf-timeline-event__description\">Un ensayo cl\u00ednico financiado por Breakthrough T1D demostr\u00f3 que el baricitinib -un inhibidor de JAK, que es cr\u00edtico para las v\u00edas de se\u00f1alizaci\u00f3n tanto dentro de las c\u00e9lulas inmunol\u00f3gicas como de las c\u00e9lulas beta en la diabetes tipo 1 (DT1)- preservaba la funci\u00f3n de las c\u00e9lulas beta en la condici\u00f3n.<\/p>\n\t\t\n\t\t\t\t\t<a\n\t\t\t\thref=\"https:\/\/www.breakthrought1d.org\/news-and-updates\/fda-approved-immune-therapy-shows-benefit-newly-diagnosed\/\"\n\t\t\t\tclass=\"wp-block-jdrf-timeline-event__link\"\n\t\t\t\t>\n\t\t\t\tM\u00e1s informaci\u00f3n sobre este ensayo cl\u00ednico\t\t\t<\/a>\n\t\t\n\t\t<span class=\"wp-block-jdrf-timeline-event__dot\"><\/span>\n\t<\/div>\n<\/div>\n\n\n<div data-motion-direction=right class=\"motion wp-block-jdrf-timeline-event\">\n\t\n\t<div class=\"wp-block-jdrf-timeline-event__content\">\n\t\t\t\t\t<span class=\"wp-block-jdrf-timeline-event__byline\">Octubre de 2023<\/span>\n\t\t\n\t\t\t\t\t\t\t\t\t<h4 class=\"wp-block-jdrf-timeline-event__title\">Ya est\u00e1n los resultados: Tzield beneficia a las personas reci\u00e9n diagnosticadas<\/h4>\n\t\t\t\t\t\n\t\t\t\t\t<p class=\"wp-block-jdrf-timeline-event__description\">Los resultados de un nuevo ensayo cl\u00ednico sugieren que Tzield tiene potencial para ralentizar la progresi\u00f3n de la DT1 en las personas diagnosticadas de DT1 de nueva aparici\u00f3n.<\/p>\n\t\t\n\t\t\t\t\t<a\n\t\t\t\thref=\"https:\/\/www.breakthrought1d.org\/news-and-updates\/results-are-out-tzield-benefits-newly-diagnosed-individuals\/\"\n\t\t\t\tclass=\"wp-block-jdrf-timeline-event__link\"\n\t\t\t\t>\n\t\t\t\tM\u00e1s informaci\u00f3n sobre este estudio\t\t\t<\/a>\n\t\t\n\t\t<span class=\"wp-block-jdrf-timeline-event__dot\"><\/span>\n\t<\/div>\n<\/div>\n\n\n<div data-motion-direction=right class=\"motion wp-block-jdrf-timeline-event\">\n\t\n\t<div class=\"wp-block-jdrf-timeline-event__content\">\n\t\t\t\t\t<span class=\"wp-block-jdrf-timeline-event__byline\">Mayo de 2023<\/span>\n\t\t\n\t\t\t\t\t\t\t\t\t<h4 class=\"wp-block-jdrf-timeline-event__title\">El p\u00e9ptido C como criterio de valoraci\u00f3n en los ensayos cl\u00ednicos: ha llegado su hora<\/h4>\n\t\t\t\t\t\n\t\t\t\t\t<p class=\"wp-block-jdrf-timeline-event__description\">Un estudio reciente dirigido por investigadores de Breakthrough T1D demuestra que el p\u00e9ptido C, un biomarcador de la producci\u00f3n de insulina, es un criterio de valoraci\u00f3n sustitutivo validado para los ensayos cl\u00ednicos de terapias modificadoras de la condici\u00f3n para la DT1.<\/p>\n\t\t\n\t\t\t\t\t<a\n\t\t\t\thref=\"https:\/\/www.breakthrought1d.org\/news-and-updates\/c-peptide-endpoint-clinical-trials-time-come\/\"\n\t\t\t\tclass=\"wp-block-jdrf-timeline-event__link\"\n\t\t\t\t>\n\t\t\t\tM\u00e1s informaci\u00f3n sobre este ensayo cl\u00ednico\t\t\t<\/a>\n\t\t\n\t\t<span class=\"wp-block-jdrf-timeline-event__dot\"><\/span>\n\t<\/div>\n<\/div>\n\n\t<\/div>\n<\/div>\n\n\n<div class=\"wp-block-jdrf-timeline-year\">\n\t\t\t<h3 class=\"wp-block-jdrf-timeline-year__year\">2022<\/h3>\n\t\n\t<div class=\"wp-block-jdrf-timeline-year__list\">\n\t\t\n<div data-motion-direction=right class=\"motion wp-block-jdrf-timeline-event\">\n\t\n\t<div class=\"wp-block-jdrf-timeline-event__content\">\n\t\t\t\t\t<span class=\"wp-block-jdrf-timeline-event__byline\">Noviembre de 2022<\/span>\n\t\t\n\t\t\t\t\t\t\t\t\t<h4 class=\"wp-block-jdrf-timeline-event__title\">La FDA aprueba Tzield, la primera terapia modificadora de la condici\u00f3n para la DT1<\/h4>\n\t\t\t\t\t\n\t\t\t\t\t<p class=\"wp-block-jdrf-timeline-event__description\">La Administraci\u00f3n de Alimentos y Medicamentos de EE.UU. (FDA) aprueba el teplizumab, bajo la marca comercial Tzield, para retrasar la aparici\u00f3n de la DT1 en personas de riesgo.<\/p>\n\t\t\n\t\t\t\t\t<a\n\t\t\t\thref=\"https:\/\/www.breakthrought1d.org\/news-and-updates\/fda-approves-tzield-teplizumab-watershed-moment-t1d-community\/\"\n\t\t\t\tclass=\"wp-block-jdrf-timeline-event__link\"\n\t\t\t\t>\n\t\t\t\tM\u00e1s informaci\u00f3n sobre este momento decisivo\t\t\t<\/a>\n\t\t\n\t\t<span class=\"wp-block-jdrf-timeline-event__dot\"><\/span>\n\t<\/div>\n<\/div>\n\n\t<\/div>\n<\/div>\n\n\n<div class=\"wp-block-jdrf-timeline-year\">\n\t\t\t<h3 class=\"wp-block-jdrf-timeline-year__year\">2021<\/h3>\n\t\n\t<div class=\"wp-block-jdrf-timeline-year__list\">\n\t\t\n<div data-motion-direction=right class=\"motion wp-block-jdrf-timeline-event\">\n\t\n\t<div class=\"wp-block-jdrf-timeline-event__content\">\n\t\t\t\t\t<span class=\"wp-block-jdrf-timeline-event__byline\">Enero de 2021<\/span>\n\t\t\n\t\t\t\t\t\t\t\t\t<h4 class=\"wp-block-jdrf-timeline-event__title\">El teplizumab est\u00e1 siendo revisado por la FDA<\/h4>\n\t\t\t\t\t\n\t\t\t\t\t<p class=\"wp-block-jdrf-timeline-event__description\">Ya est\u00e1 en marcha la revisi\u00f3n reglamentaria por parte de la Administraci\u00f3n de Alimentos y Medicamentos de EE.UU. (FDA) del teplizumab -una terapia que bloquea el marcador sangu\u00edneo CD3, que activa las c\u00e9lulas inmunitarias- para retrasar la DT1 en personas de riesgo.<\/p>\n\t\t\n\t\t\t\t\t<a\n\t\t\t\thref=\"https:\/\/www.breakthrought1d.org\/news-and-updates\/official-teplizumab-under-review-fda\/\"\n\t\t\t\tclass=\"wp-block-jdrf-timeline-event__link\"\n\t\t\t\t>\n\t\t\t\tM\u00e1s informaci\u00f3n sobre esta terapia modificadora de la condici\u00f3n\t\t\t<\/a>\n\t\t\n\t\t<span class=\"wp-block-jdrf-timeline-event__dot\"><\/span>\n\t<\/div>\n<\/div>\n\n\n<div data-motion-direction=right class=\"motion wp-block-jdrf-timeline-event\">\n\t\n\t<div class=\"wp-block-jdrf-timeline-event__content\">\n\t\t\t\t\t<span class=\"wp-block-jdrf-timeline-event__byline\">Febrero 2021<\/span>\n\t\t\n\t\t\t\t\t\t\t\t\t<h4 class=\"wp-block-jdrf-timeline-event__title\">Breakthrough T1D se asocia con la Alianza de Investigaci\u00f3n sobre el Lupus y la Sociedad Nacional de Esclerosis M\u00faltiple<\/h4>\n\t\t\t\t\t\n\t\t\t\t\t<p class=\"wp-block-jdrf-timeline-event__description\">Las organizaciones se asocian para avanzar en la comprensi\u00f3n de la autoinmunidad y obtener conocimientos m\u00e1s espec\u00edficos sobre los aspectos comunes y las diferencias de las v\u00edas inmunitarias que rigen estos procesos patol\u00f3gicos.<\/p>\n\t\t\n\t\t\t\t\t<a\n\t\t\t\thref=\"https:\/\/www.breakthrought1d.org\/for-the-media\/press-releases\/jdrf-lupus-research-alliance-and-national-multiple-sclerosis-society-join-forces-to-decode-common-mechanisms-of-autoimmune-diseases\/\"\n\t\t\t\tclass=\"wp-block-jdrf-timeline-event__link\"\n\t\t\t\t>\n\t\t\t\tM\u00e1s informaci\u00f3n sobre esta Alianza\t\t\t<\/a>\n\t\t\n\t\t<span class=\"wp-block-jdrf-timeline-event__dot\"><\/span>\n\t<\/div>\n<\/div>\n\n\t<\/div>\n<\/div>\n\n\n<div class=\"wp-block-jdrf-timeline-year\">\n\t\t\t<h3 class=\"wp-block-jdrf-timeline-year__year\">2020<\/h3>\n\t\n\t<div class=\"wp-block-jdrf-timeline-year__list\">\n\t\t\n<div data-motion-direction=right class=\"motion wp-block-jdrf-timeline-event\">\n\t\n\t<div class=\"wp-block-jdrf-timeline-event__content\">\n\t\t\t\t\t<span class=\"wp-block-jdrf-timeline-event__byline\">Diciembre 2020<\/span>\n\t\t\n\t\t\t\t\t\t\t\t\t<h4 class=\"wp-block-jdrf-timeline-event__title\">Los inhibidores de JAK comienzan los ensayos cl\u00ednicos en humanos<\/h4>\n\t\t\t\t\t\n\t\t\t\t\t<p class=\"wp-block-jdrf-timeline-event__description\">El ensayo cl\u00ednico BANDIT comenz\u00f3 en Australia, para averiguar si un inhibidor de JAK, llamado baricitinib, preservar\u00e1 la funci\u00f3n de las c\u00e9lulas beta en ni\u00f1os y adultos j\u00f3venes con DT1 reci\u00e9n diagnosticada.<\/p>\n\t\t\n\t\t\t\t\t<a\n\t\t\t\thref=\"\"\n\t\t\t\tclass=\"wp-block-jdrf-timeline-event__link\"\n\t\t\t\t>\n\t\t\t\tM\u00e1s informaci\u00f3n sobre este ensayo cl\u00ednico\t\t\t<\/a>\n\t\t\n\t\t<span class=\"wp-block-jdrf-timeline-event__dot\"><\/span>\n\t<\/div>\n<\/div>\n\n\t<\/div>\n<\/div>\n\n\t<\/div>\n<\/section>\n\n\n\n<div class=\"wp-block-group alignfull has-white-color has-navy-background-color has-text-color has-background has-link-color wp-elements-15cf1198b140c2c333206e810bb76e72 is-layout-constrained wp-block-group-is-layout-constrained\">\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-e50f5278 wp-block-columns-is-layout-flex has-2-columns\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<h2 class=\"wp-block-heading\" id=\"amazing-progress\">Progresos asombrosos  <\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">En la \u00faltima d\u00e9cada, Breakthrough T1D ha invertido m\u00e1s de 273 millones de d\u00f3lares en terapias modificadoras de la condici\u00f3n, y hay varias en ensayos cl\u00ednicos humanos. Una terapia, Tzield, ha sido incluso aprobada por la FDA para su uso en el retraso de la aparici\u00f3n de la Etapa 3 de la DT1. M\u00e1s informaci\u00f3n sobre la aprobaci\u00f3n de Tzield por la FDA.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-637419bb wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\">Read More<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-group alignfull is-layout-constrained wp-block-group-is-layout-constrained\">\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-e50f5278 wp-block-columns-is-layout-flex has-2-columns\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<h2 class=\"wp-block-heading\" id=\"learn-more-about-our-research\">M\u00e1s informaci\u00f3n sobre nuestra investigaci\u00f3n<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Breakthrough T1D trabaja para mejorar la vida de todos los afectados por la condici\u00f3n.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\"><\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-bee6419c wp-block-columns-is-layout-flex has-3-columns\" style=\"margin-top:var(--wp--preset--spacing--40)\">\n<div class=\"wp-block-column has-light-gray-background-color has-background is-layout-flow wp-block-column-is-layout-flow\" style=\"padding-top:var(--wp--preset--spacing--24);padding-right:var(--wp--preset--spacing--16);padding-bottom:var(--wp--preset--spacing--24);padding-left:var(--wp--preset--spacing--16)\">\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button is-style-large-link\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/www.breakthrought1d.org\/es\/explora-investigacion\/estrategia-investigacion\/\">Estrategia de investigaci\u00f3n<\/a><\/div>\n<\/div>\n\n\n\n<p class=\"wp-block-paragraph\">Nuestra estrategia de investigaci\u00f3n tiene dos pilares: curar la DT1 y mejorar la vida cotidiana de las personas con DT1.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column has-light-gray-background-color has-background is-layout-flow wp-block-column-is-layout-flow\" style=\"padding-top:var(--wp--preset--spacing--24);padding-right:var(--wp--preset--spacing--16);padding-bottom:var(--wp--preset--spacing--24);padding-left:var(--wp--preset--spacing--16)\">\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button is-style-large-link\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/www.breakthrought1d.org\/es\/noticias-y-actualizaciones\/?topic=research\">Noticias de investigaci\u00f3n<\/a><\/div>\n<\/div>\n\n\n\n<p class=\"wp-block-paragraph\">Las \u00faltimas noticias sobre la investigaci\u00f3n de la DT1 y actualizaciones sobre la comunidad de DT1.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column has-light-gray-background-color has-background is-layout-flow wp-block-column-is-layout-flow\" style=\"padding-top:var(--wp--preset--spacing--24);padding-right:var(--wp--preset--spacing--16);padding-bottom:var(--wp--preset--spacing--24);padding-left:var(--wp--preset--spacing--16)\">\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button is-style-large-link\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/www.breakthrought1d.org\/es\/explora-investigacion\/mejorando-vidas\/\">Mejorar vidas<\/a><\/div>\n<\/div>\n\n\n\n<p class=\"wp-block-paragraph\">Hoy lideramos el camino hacia soluciones m\u00e1s eficaces. Ma\u00f1ana haremos que esta condici\u00f3n sea cosa del pasado.<\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false,"raw":""},"excerpt":{"rendered":"<p>Nuestro enfoque La diabetes tipo 1 (DT1) es una condici\u00f3n autoinmune en la que el sistema inmunol\u00f3gico del organismo destruye las c\u00e9lulas beta del p\u00e1ncreas, haci\u00e9ndolas dependientes de por vida de la administraci\u00f3n externa de insulina. Breakthrough T1D se centra en desarrollar f\u00e1rmacos, o terapias modificadoras de la condici\u00f3n, que cambien el curso de la [&hellip;]<\/p>\n","protected":false},"author":1100,"featured_media":0,"parent":211866,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"ep_exclude_from_search":false,"publish_on_app_meta":"True","iawp_total_views":43,"footnotes":""},"class_list":["post-215660","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Terapias modificadoras de la enfermedad - Breakthrough T1D<\/title>\n<meta name=\"description\" content=\"Las terapias modificadoras de la enfermedad ralentizan, detienen y revierten la diabetes tipo 1 (T1D). Breakthrough T1D ha invertido millones en esta investigaci\u00f3n.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.breakthrought1d.org\/es\/explora-investigacion\/cura-dt1\/terapias-modificadoras-de-la-enfermedad\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Terapias modificadoras de la enfermedad - Breakthrough T1D\" \/>\n<meta property=\"og:description\" content=\"Las terapias modificadoras de la enfermedad ralentizan, detienen y revierten la diabetes tipo 1 (T1D). Breakthrough T1D ha invertido millones en esta investigaci\u00f3n.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.breakthrought1d.org\/es\/explora-investigacion\/cura-dt1\/terapias-modificadoras-de-la-enfermedad\/\" \/>\n<meta property=\"og:site_name\" content=\"Breakthrough T1D\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/breakthrought1dHQ\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-16T17:50:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.breakthrought1d.org\/wp-content\/uploads\/2024\/06\/BreakthroughT1D-Icon_Blues_RGB__Immunce-activation.png\" \/>\n\t<meta property=\"og:image:width\" content=\"876\" \/>\n\t<meta property=\"og:image:height\" content=\"876\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@breakthrought1d\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/es\\\/explora-investigacion\\\/cura-dt1\\\/terapias-modificadoras-de-la-enfermedad\\\/\",\"url\":\"https:\\\/\\\/www.breakthrought1d.org\\\/es\\\/explora-investigacion\\\/cura-dt1\\\/terapias-modificadoras-de-la-enfermedad\\\/\",\"name\":\"Terapias modificadoras de la enfermedad - Breakthrough T1D\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/es\\\/explora-investigacion\\\/cura-dt1\\\/terapias-modificadoras-de-la-enfermedad\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/es\\\/explora-investigacion\\\/cura-dt1\\\/terapias-modificadoras-de-la-enfermedad\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.breakthrought1d.org\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/BreakthroughT1D-Icon_Blues_RGB__Immunce-activation.png\",\"datePublished\":\"2024-06-27T14:57:07+00:00\",\"dateModified\":\"2025-07-16T17:50:51+00:00\",\"description\":\"Las terapias modificadoras de la enfermedad ralentizan, detienen y revierten la diabetes tipo 1 (T1D). Breakthrough T1D ha invertido millones en esta investigaci\u00f3n.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/es\\\/explora-investigacion\\\/cura-dt1\\\/terapias-modificadoras-de-la-enfermedad\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.breakthrought1d.org\\\/es\\\/explora-investigacion\\\/cura-dt1\\\/terapias-modificadoras-de-la-enfermedad\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/es\\\/explora-investigacion\\\/cura-dt1\\\/terapias-modificadoras-de-la-enfermedad\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.breakthrought1d.org\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/BreakthroughT1D-Icon_Blues_RGB__Immunce-activation.png\",\"contentUrl\":\"https:\\\/\\\/www.breakthrought1d.org\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/BreakthroughT1D-Icon_Blues_RGB__Immunce-activation.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/es\\\/explora-investigacion\\\/cura-dt1\\\/terapias-modificadoras-de-la-enfermedad\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/www.breakthrought1d.org\\\/es\\\/pagina-de-actualizacion-de-test\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Explora nuestra investigaci\u00f3n\",\"item\":\"https:\\\/\\\/www.breakthrought1d.org\\\/es\\\/explora-investigacion\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Cura\",\"item\":\"https:\\\/\\\/www.breakthrought1d.org\\\/es\\\/explora-investigacion\\\/cura-dt1\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Terapias modificadoras de la enfermedad\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.breakthrought1d.org\\\/es\\\/\",\"name\":\"Breakthrough T1D\",\"description\":\"Improving Lives. Curing Type 1 Diabetes.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.breakthrought1d.org\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/es\\\/#organization\",\"name\":\"Breakthrough T1D\",\"url\":\"https:\\\/\\\/www.breakthrought1d.org\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.breakthrought1d.org\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/BT1D-favi.png\",\"contentUrl\":\"https:\\\/\\\/www.breakthrought1d.org\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/BT1D-favi.png\",\"width\":400,\"height\":400,\"caption\":\"Breakthrough T1D\"},\"image\":{\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/breakthrought1dHQ\",\"https:\\\/\\\/x.com\\\/breakthrought1d\",\"https:\\\/\\\/www.youtube.com\\\/@breakthrought1d\",\"https:\\\/\\\/www.instagram.com\\\/breakthrought1d\\\/\",\"https:\\\/\\\/www.tiktok.com\\\/@breakthrought1dhq\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Terapias modificadoras de la enfermedad - Breakthrough T1D","description":"Las terapias modificadoras de la enfermedad ralentizan, detienen y revierten la diabetes tipo 1 (T1D). Breakthrough T1D ha invertido millones en esta investigaci\u00f3n.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.breakthrought1d.org\/es\/explora-investigacion\/cura-dt1\/terapias-modificadoras-de-la-enfermedad\/","og_locale":"es_ES","og_type":"article","og_title":"Terapias modificadoras de la enfermedad - Breakthrough T1D","og_description":"Las terapias modificadoras de la enfermedad ralentizan, detienen y revierten la diabetes tipo 1 (T1D). Breakthrough T1D ha invertido millones en esta investigaci\u00f3n.","og_url":"https:\/\/www.breakthrought1d.org\/es\/explora-investigacion\/cura-dt1\/terapias-modificadoras-de-la-enfermedad\/","og_site_name":"Breakthrough T1D","article_publisher":"https:\/\/www.facebook.com\/breakthrought1dHQ","article_modified_time":"2025-07-16T17:50:51+00:00","og_image":[{"width":876,"height":876,"url":"https:\/\/www.breakthrought1d.org\/wp-content\/uploads\/2024\/06\/BreakthroughT1D-Icon_Blues_RGB__Immunce-activation.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@breakthrought1d","twitter_misc":{"Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.breakthrought1d.org\/es\/explora-investigacion\/cura-dt1\/terapias-modificadoras-de-la-enfermedad\/","url":"https:\/\/www.breakthrought1d.org\/es\/explora-investigacion\/cura-dt1\/terapias-modificadoras-de-la-enfermedad\/","name":"Terapias modificadoras de la enfermedad - Breakthrough T1D","isPartOf":{"@id":"https:\/\/www.breakthrought1d.org\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.breakthrought1d.org\/es\/explora-investigacion\/cura-dt1\/terapias-modificadoras-de-la-enfermedad\/#primaryimage"},"image":{"@id":"https:\/\/www.breakthrought1d.org\/es\/explora-investigacion\/cura-dt1\/terapias-modificadoras-de-la-enfermedad\/#primaryimage"},"thumbnailUrl":"https:\/\/www.breakthrought1d.org\/wp-content\/uploads\/2024\/06\/BreakthroughT1D-Icon_Blues_RGB__Immunce-activation.png","datePublished":"2024-06-27T14:57:07+00:00","dateModified":"2025-07-16T17:50:51+00:00","description":"Las terapias modificadoras de la enfermedad ralentizan, detienen y revierten la diabetes tipo 1 (T1D). Breakthrough T1D ha invertido millones en esta investigaci\u00f3n.","breadcrumb":{"@id":"https:\/\/www.breakthrought1d.org\/es\/explora-investigacion\/cura-dt1\/terapias-modificadoras-de-la-enfermedad\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.breakthrought1d.org\/es\/explora-investigacion\/cura-dt1\/terapias-modificadoras-de-la-enfermedad\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.breakthrought1d.org\/es\/explora-investigacion\/cura-dt1\/terapias-modificadoras-de-la-enfermedad\/#primaryimage","url":"https:\/\/www.breakthrought1d.org\/wp-content\/uploads\/2024\/06\/BreakthroughT1D-Icon_Blues_RGB__Immunce-activation.png","contentUrl":"https:\/\/www.breakthrought1d.org\/wp-content\/uploads\/2024\/06\/BreakthroughT1D-Icon_Blues_RGB__Immunce-activation.png"},{"@type":"BreadcrumbList","@id":"https:\/\/www.breakthrought1d.org\/es\/explora-investigacion\/cura-dt1\/terapias-modificadoras-de-la-enfermedad\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/www.breakthrought1d.org\/es\/pagina-de-actualizacion-de-test\/"},{"@type":"ListItem","position":2,"name":"Explora nuestra investigaci\u00f3n","item":"https:\/\/www.breakthrought1d.org\/es\/explora-investigacion\/"},{"@type":"ListItem","position":3,"name":"Cura","item":"https:\/\/www.breakthrought1d.org\/es\/explora-investigacion\/cura-dt1\/"},{"@type":"ListItem","position":4,"name":"Terapias modificadoras de la enfermedad"}]},{"@type":"WebSite","@id":"https:\/\/www.breakthrought1d.org\/es\/#website","url":"https:\/\/www.breakthrought1d.org\/es\/","name":"Breakthrough T1D","description":"Improving Lives. Curing Type 1 Diabetes.","publisher":{"@id":"https:\/\/www.breakthrought1d.org\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.breakthrought1d.org\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.breakthrought1d.org\/es\/#organization","name":"Breakthrough T1D","url":"https:\/\/www.breakthrought1d.org\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.breakthrought1d.org\/es\/#\/schema\/logo\/image\/","url":"https:\/\/www.breakthrought1d.org\/wp-content\/uploads\/2024\/06\/BT1D-favi.png","contentUrl":"https:\/\/www.breakthrought1d.org\/wp-content\/uploads\/2024\/06\/BT1D-favi.png","width":400,"height":400,"caption":"Breakthrough T1D"},"image":{"@id":"https:\/\/www.breakthrought1d.org\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/breakthrought1dHQ","https:\/\/x.com\/breakthrought1d","https:\/\/www.youtube.com\/@breakthrought1d","https:\/\/www.instagram.com\/breakthrought1d\/","https:\/\/www.tiktok.com\/@breakthrought1dhq"]}]}},"_links":{"self":[{"href":"https:\/\/www.breakthrought1d.org\/es\/wp-json\/wp\/v2\/pages\/215660","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.breakthrought1d.org\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.breakthrought1d.org\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.breakthrought1d.org\/es\/wp-json\/wp\/v2\/users\/1100"}],"replies":[{"embeddable":true,"href":"https:\/\/www.breakthrought1d.org\/es\/wp-json\/wp\/v2\/comments?post=215660"}],"version-history":[{"count":0,"href":"https:\/\/www.breakthrought1d.org\/es\/wp-json\/wp\/v2\/pages\/215660\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/www.breakthrought1d.org\/es\/wp-json\/wp\/v2\/pages\/211866"}],"wp:attachment":[{"href":"https:\/\/www.breakthrought1d.org\/es\/wp-json\/wp\/v2\/media?parent=215660"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}